Position
Parallel Advisors, LLC in Amneal Pharmaceuticals, Inc.
Back to the book · All holders of AMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$23$12.60 → $12.43
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 131 | $1.65K | — | — | — | 0.0% |
| Q1 2026 | 721 | $8.96K | $12.43 | −$23 | $7.33K | 0.0% |